Market Research Industry Reports

Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Leap Therapeutics Inc (LPTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The companys pipeline products include DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, intended for the treatment of gastroesophageal cancer, biliary tract cancer, hepatocellular carcinoma, and non-small cell lung cancer; and TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune systems anti-tumor response and is in Phase 1 clinical trials intended for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc Key Recent Developments

May 11,2018: Leap Therapeutics Reports First Quarter 2018 Financial Results
Feb 23,2018: Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
Nov 13,2017: Leap Therapeutics Reports Third Quarter 2017 Financial Results
Aug 11,2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results
May 12,2017: Leap Therapeutics Reports First Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Leap Therapeutics Inc - Key Facts 5
Leap Therapeutics Inc - Key Employees 6
Leap Therapeutics Inc - Key Employee Biographies 7
Leap Therapeutics Inc - Major Products and Services 8
Leap Therapeutics Inc - History 9
Leap Therapeutics Inc - Company Statement 10
Leap Therapeutics Inc - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 12
Leap Therapeutics Inc - Business Description 12
Leap Therapeutics Inc - SWOT Analysis 13
SWOT Analysis - Overview 13
Leap Therapeutics Inc - Strengths 13
Leap Therapeutics Inc - Weaknesses 14
Leap Therapeutics Inc - Opportunities 15
Leap Therapeutics Inc - Threats 16
Leap Therapeutics Inc - Key Competitors 17
Section 3 Company Financial Ratios 18
Financial Ratios - Capital Market Ratios 18
Financial Ratios - Annual Ratios 19
Performance Chart 21
Financial Performance 21
Financial Ratios - Interim Ratios 22
Financial Ratios - Ratio Charts 23
Section 4 Companys Lifesciences Financial Deals and Alliances 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Leap Therapeutics Inc, Recent Deals Summary 26
Section 5 Companys Recent Developments 27
May 11, 2018: Leap Therapeutics Reports First Quarter 2018 Financial Results 27
Nov 13, 2017: Leap Therapeutics Reports Third Quarter 2017 Financial Results 29
Aug 11, 2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results 30
May 12, 2017: Leap Therapeutics Reports First Quarter 2017 Financial Results 31
May 12, 2017: Leap Therapeutics Q1 net loss increases 32
Mar 31, 2017: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers 33
Section 6 Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List Of Tables

List of Tables
Leap Therapeutics Inc, Key Facts 5
Leap Therapeutics Inc, Key Employees 6
Leap Therapeutics Inc, Key Employee Biographies 7
Leap Therapeutics Inc, Major Products and Services 8
Leap Therapeutics Inc, History 9
Leap Therapeutics Inc, Subsidiaries 11
Leap Therapeutics Inc, Key Competitors 17
Leap Therapeutics Inc, Ratios based on current share price 18
Leap Therapeutics Inc, Annual Ratios 19
Leap Therapeutics Inc, Annual Ratios (Cont...1) 20
Leap Therapeutics Inc, Interim Ratios 22
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 25
Leap Therapeutics Inc, Recent Deals Summary 26
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List Of Figures

List of Figures
Leap Therapeutics Inc, Performance Chart (2014 - 2017) 21
Leap Therapeutics Inc, Ratio Charts 23
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 24
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 25

Leap Therapeutics Inc (LPTX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The companys pipeline products include DKN-01, a

USD 250View Report

LEAP Holdings Group Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

LEAP Holdings Group Limited Company Profile is a detailed strategic and analytical report on LEAP Holdings Group Limited. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Sangamo Therapeutics Inc (SGMO) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sangamo Therapeutics Inc (Sangamo), formerly Sangamo BioSciences Inc, is a clinical stage biotechnology company that focuses on the research, development and commercialization of engineered DNA-binding proteins (ZFPs) for gene regulation,

USD 250View Report

TG Therapeutics Inc (TGTX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

TG Therapeutics Inc (TG Therapeutics) is a biopharmaceutical company which acquires, develops and commercializes pharmaceutical products for the treatment of B-cell malignancies and autoimmune diseases. The company develops two therapies,

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : May 2018
No. of Pages :38
Country :United States of America
Category :Swot Analysis
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube